Rapid Action Against MRSA
Rapid, noninvasive testing is increasingly valuable in the fight against antibiotic resistance
Michael Schubert | | Quick Read
Antibiotic resistance is a growing threat to worldwide health. In the USA alone, methicillin-resistant Staphylococcus aureus (MRSA) is estimated to have caused 323,700 cases and 10,600 deaths in 2019 (1). As these numbers continue to rise, it’s more important than ever that we detect these infections quickly so that treating physicians can make effective decisions.
At the moment, hospitals apply a “search and destroy” policy that assumes every patient is at risk of MRSA. However, effective detection of the pathogen requires rapid, accessible diagnostic technology. To this end, single-step identification of MRSA, especially from noninvasive testing, such as nasal swabs, is increasingly valuable. One such technology, presented at the recent MedLab Middle East conference (2), offers MRSA detection in just 15 minutes – a timeline that allows rapid management and the opportunity to prevent the spread of antibiotic resistance.